CD4 and malignant colon neoplasm: This study revealed that the high-risk group had higher levels of M0 macrophages and fibroblasts, while activated mast cells, resting CD4+T cells and dendritic cells activated were less abundant, implying that the risk model constructed in this study can be used as a biomarker to predict the immune status of colon cancer.